DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
Nik Modi - 9 Modi - 8 it's - 4 Nik Modi Nik Modi - 4 It's - 2 Coke - 2 Eli Lilly - 2 Morgan Stanley - 2
Top related locs:
U.S North America United States Europe Shanghai China Kyiv Ukraine
Top related orgs:
RBC Capital Markets - 8 CNBC - 4 RBC Capital - 3 Procter - 2 Getty - 2 Cola - 2 Deutsche Bank - 2 Service - 2

Search resuls for: "Nik Modi"


14 mentions found


☆ Procter & Gamble's strategic pricing shift should accelerate business growth this year
  + stars: | 2024-04-18 | by ( Paulina Likos | ) www.cnbc.com   time to read: +6 min
Those are key items to watch out for Friday morning when P & G reports its fiscal 2024 third-quarter earnings. Shares of P & G hit a multiyear high of $163 on March 28 — less than $2 per share below all-time highs reached in late April 2022. Traditionally for Procter, pricing has contributed low single digits to its earnings growth. In P & G's fiscal second quarter , pricing contributed 4% to sales growth, but volumes were down on a companywide basis. He expects to see a healthy organic growth rate consistent with the 4% organic growth reported in the second quarter.
Persons: Jeff Marks, Jim Cramer, Nik Modi, Modi, Procter, Jon Anderson, William Blair, Anderson, Ulta, Jim Cramer's, Jim Organizations: Procter, Gamble, CNBC, Federal Reserve, Fed, RBC Capital Markets, Anderson, China, National Exhibition, Convention Center, VCG, Getty Locations: U.S, North America, Shanghai, China
☆ Top Wall Street analysts pick these dividend stocks for enhanced returns
  + stars: | 2024-02-25 | by ( Tipranks.Com Staff | ) www.cnbc.com   time to read: +5 min
The Coca-Cola Company logo is being displayed at a New Year's fair in Kyiv, Ukraine, on December 31, 2023. Investors looking to enhance their portfolio returns can opt for a combination of growth and dividend stocks. Choosing the right dividend stock by analyzing multiple factors can be complex for investors. However, recommendations from analysts can help inform investors' research and guide them toward lucrative dividend stocks from companies with strong fundamentals. Here are three attractive dividend stocks, according to Wall Street's top experts on TipRanks, a platform that ranks analysts based on their past performance.
Persons: Wall, Nik Modi, Modi, TipRanks, Brian Bedell, mgmt, Bedell, Goldman Sachs, Neil Mehta, Hess, Mehta Organizations: Cola, RBC Capital, Owl, Deutsche Bank, Chevron Oil, Chevron, CNBC PRO Locations: Kyiv, Ukraine, Chevron, Kazakhstan
☆ Why Monster Beverage is the best-performing stock of the last 30 years
  + stars: | 2024-02-17 | by ( Natalie Rice | ) www.cnbc.com   time to read: +3 min
It's actually an energy drink company: Monster Beverage . Monster's stock has climbed for decades, along with sales, which have grown consistently for 31 years straight. Between Feb. 14, 1994, and Wednesday, Monster's stock appreciated by about 200,000%. Monster Beverage is a holding company composed of subsidiaries that produce and manufacture drinks including energy, alcohol, teas and coffees. The company attracted the attention of beverage giant Coca-Cola , which entered into a strategic partnership with the company now called Monster Beverage in 2015.
Persons: It's, Rodney Sacks, Hilton Schlosberg, Mark Astrachan, Sacks, Schlosberg, Monster, Nik Modi, Modi, Coke, Monster's, they've Organizations: Monster Beverage, South, Beverage, Energy, Natural Corporation, Capital Markets, Analysts, Nascar
☆ Your tax dollars are getting spent on weight-loss drugs like Ozempic, and the total is adding up
  + stars: | 2024-01-11 | by ( Juliana Kaplan | Ayelet Sheffey | ) www.businessinsider.com   time to read: +7 min
AdvertisementConnecticut was quick to experience the impact of weight loss drugs on its economy last year. Politico reported in November that the state's employee health plan was set to spend $30 million on drugs like Ozempic and Wegovy. Comptroller Sean Scanlon told BI that that was up from $8 million in 2020. Connecticut began testing out a method to offer those seeking weight loss drugs access to a program with online tools for weight management. In North Carolina, the State Health Plan has put a moratorium on new users of GLP-1 drugs for weight loss.
Persons: Sean Scanlon, Scanlon, it's, Dale Folwell, Folwell, Shelby Livingston, Eli Lilly, that'll, Nik Modi Organizations: Service, Business, Bloomberg, Medicaid, Politico, BI, State, North, State Health, Novo Nordisk, Wall Street, University of Texas System, UT, RBC Capital Markets Locations: Connecticut, Wegovy, . Connecticut, North Carolina, Novo, Netherlands, United States
☆ December's 'best-in-class' stocks include this obesity beneficiary, Wall Street analysts say
  + stars: | 2023-12-02 | by ( Michael Bloom | ) www.cnbc.com   time to read: +6 min
An obesity beneficiary and a snack foods company are just a few of the top stocks to buy in December, analysts said this week. Wall Street research firms named a slew of companies that they believe have upside heading into the years end. Obin said the company has a "preponderance" of margin tailwinds for 2024, including "differentiated auto exposure, underappreciated margin expansion opportunities, and best-in-class execution." "We are including BUY-rated EL in our research team's Best-of-Breed Bison initiative, which focuses on long-term best-in-class companies with sustainable competitive moats," analyst Linda Bolton Weiser said earlier this week. Estee Lauder — DA Davidson, buy rating "We are including BUY-rated EL in our research team's Best-of-Breed Bison initiative, which focuses on long-term best-in-class companies with sustainable competitive moats.
Persons: Estee Lauder, Gracell Biotechnologies, Eli Lilly, Andrew Obin, Obin, it's, Nik Modi, Modi, MDLZ, Mondelez, LSEG, Estee Lauder DA Davidson, Linda Bolton Weiser, Bolton Weiser, Gracell, Eli Lilly — Morgan Stanley, Estee Lauder —, Davidson Organizations: CNBC, ITT, Gracell, Bank of America, RBC, ISI, pharma, ITT — Bank of America
☆ Monday's analyst calls: Big pharma upgrade, top 'clean tech' play
  + stars: | 2023-11-27 | by ( Lisa Kailai Han Fred Imbert | Lisa Kailai Han | Fred Imbert | ) www.cnbc.com   time to read: +11 min
☆ How Ozempic could change the economy as we know it
  + stars: | 2023-11-05 | by ( Cork Gaines | ) www.businessinsider.com   time to read: +6 min
A new wave of weight loss drugs could lead to indirect effects for all kinds of companies. Ozempic is a brand name for semaglutide, a diabetes drug that also has weight loss effects. Walmart, for example, which sells Ozempic and other GLP-1 drugs, found that customers buying those medications spent less on food year over year but more on lifestyle and fitness. Additionally, employee productivity could increase as Americans see the long-term benefits of weight loss and stay in the workforce longer. AdvertisementAdvertisementFor example, Walmart, which sells GLP-1 drugs like Ozempic, found that customers buying those medications spent less on food year over year but more on lifestyle and fitness.
Persons: It's, —, it's, Nik Modi, Modi, Josh Barro, Barro, Morgan Stanley, Scott Olson, they're, Houlihan Lawrence, James van Geelen, van Geelen Organizations: Service, Walmart, RBC Capital Markets, Jefferies, United Airlines, Citrinitas
☆ Coke and Pepsi stocks are both struggling — but one beverage giant has more to worry about than the other
  + stars: | 2023-10-28 | by ( Amelia Lucas | ) www.cnbc.com   time to read: +6 min
Coke's overall volume rose 2% in the third quarter, while Pepsi reported flat beverage volume and a 1.5% decline in its food volume. Coke reported flat volume, while Pepsi's North American beverage unit saw volume fall 6%. "Coke has been taking share from Pepsi for many, many quarters," RBC Capital Markets analyst Nik Modi said. McDonald's has served Coke products since Ray Kroc opened his first franchised location, and is the beverage company's largest restaurant customer. International success can offset more sluggish domestic demand, like the 6% volume decline for Pepsi's North American beverage.
Persons: Luke Sharrett, Coke, James Quincey, Edward Jones, Brittany Quatrochi, Nik Modi, snacking, Modi, Quincey, McDonald's, Ray Kroc, Taco, Quatrochi Organizations: Pepsi Co, Bloomberg, Getty, Cola, PepsiCo, Coke, Atlanta -, Pepsi, Pepsi's, Gatorade, RBC Capital, Frito, U.S, Taco Bell, Yum Brands Locations: Jasper , Indiana, Atlanta, North America, United States, Europe, North, U.S, Argentina, Turkey
☆ The real-world impact of weight loss drugs is less than clinical studies, says RBC's Nik Modi
  + stars: | 2023-10-20 | by ( ) www.cnbc.com   time to read: 1 min
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailThe real-world impact of weight loss drugs is less than clinical studies, says RBC's Nik ModiNik Modi, RBC Capital Markets analyst, joins 'Squawk on the Street' to discuss the real-world impact of weight loss drugs on consumers, how beverage companies are faring, and more.
Persons: Nik Modi Nik Modi Organizations: RBC Capital Markets
☆ Fundamentals are deteriorating for consumer staples, says RBC's Nik Modi
  + stars: | 2023-10-06 | by ( ) www.cnbc.com   time to read: 1 min
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailFundamentals are deteriorating for consumer staples, says RBC's Nik ModiNik Modi, RBC Capital Markets analyst, joins 'Squawk on the Street' to discuss what's driving the sell-off in consumer staple stocks, whether Modi would be buying on the recent pullbacks, and more.
Persons: Nik Modi Nik Modi, Modi Organizations: RBC Capital Markets
☆ Consumer staples should start to see more weakness in the coming months, says RBC's Nik Modi
  + stars: | 2023-09-05 | by ( ) www.cnbc.com   time to read: 1 min
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailConsumer staples should start to see more weakness in the coming months, says RBC's Nik ModiNik Modi, RBC Capital Markets analyst, joins 'Power Lunch' to discuss the macro impact on consumer staples, consumer spending reflecting trade down trends and brands with international exposure doing well in emerging markets because of inflation.
Persons: Nik Modi Nik Modi Organizations: RBC Capital Markets
☆ P&G is showing it's a best-in-class operator in its industry, says RBC's Nik Modi
  + stars: | 2023-07-28 | by ( ) www.cnbc.com   time to read: 1 min
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailP&G is showing it's a best-in-class operator in its industry, says RBC's Nik ModiNik Modi, RBC Capital Markets analyst, joins 'Squawk on the Street' to discuss his takeaways from Procter & Gamble's earnings call, what the company did to separate itself from peers, and more.
Persons: it's, Nik Modi Nik Modi Organizations: RBC Capital Markets, Procter
☆ Kenvue CEO says consumers are spending on brand-name health products even as they pull back in other areas
  + stars: | 2023-07-21 | by ( Annika Kim Constantino | ) www.cnbc.com   time to read: +3 min
Most consumers have pulled back on spending as inflation squeezes their wallets, but they have not stopped paying up for brand-name health and personal care products, Kenvue CEO Thibaut Mongon said. Kenvue also noted that "private label" penetration in the consumer health product market was stable for the quarter. Those spending trends could bode well not only for Kenvue, but also for other companies in the consumer health, beauty and beverage spaces that may not see consumers trade down to cheaper products as often despite stubbornly high prices. RBC Capital analyst Nik Modi expressed confidence in Kenvue's ability to "maintain its momentum," highlighting consumer trust in the company's brands and health and personal care products overall. Meanwhile, Kenvue has gained market share, and could potentially continue to do so despite the broader environment, he noted.
Persons: Thibaut Mongon, Johnson, Mongon, Kenvue, bode, we've, Nik Modi, Modi Organizations: Kenvue Inc, New York Stock Exchange, CNBC, Johnson, J, RBC Capital Locations: Kenvue
☆ TipRanks reveals the top 10 consumer goods sector analysts of the past decade
  + stars: | 2023-05-28 | by ( Tipranks.Com Staff | ) www.cnbc.com   time to read: +4 min
TipRanks recognized Wall Street's 10 best analysts in the consumer goods sector for identifying the best investment opportunities. TipRanks used its Experts Center tool to identify the pros with a high success rate, and analyzed each stock recommendation made by analysts in the consumer goods sector over the past decade. TipRanks' algorithms calculated the statistical significance of each rating, the analysts' overall success rate and the average return. Top 10 analysts from the consumer goods sectorThe image below shows the most successful Wall Street analysts from the consumer goods sector. Mark Astrachan - Stifel NicolausMark Astrachan has the 10th spot on the list, with a success rate of 65%.
0 next >>
Total: 14